US equities
|
INTC
$119.13
▼-0.17%
MU
$1,074.89
▲+0.00%
META
$728.08
▲+0.00%
NVDA
$233.95
▲+0.00%
TSLA
$370.59
▲+0.00%
AMD
$633.91
▲+0.00%
SPCX
$158.96
▲+0.00%
JNJ
$256.03
▲+0.00%
INTC
$119.13
▼-0.17%
MU
$1,074.89
▲+0.00%
META
$728.08
▲+0.00%
NVDA
$233.95
▲+0.00%
TSLA
$370.59
▲+0.00%
AMD
$633.91
▲+0.00%
SPCX
$158.96
▲+0.00%
JNJ
$256.03
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Lifeward Ltd. - Ordinary Shares
(NQ:
LFWD
)
5.850
UNCHANGED
Delayed Quote
Updated: 3:59 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Lifeward Ltd. - Ordinary Shares
< Previous
1
2
3
4
5
Next >
Peer-Reviewed Study of Lifeward’s ReWalk® Exoskeleton Reports Significant Improvements in Daily Activity Performance, Satisfaction, and Pain
September 15, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward Publishes Updated Investor Presentation Highlighting Commercial Growth Strategy
September 08, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward Appoints Josh Hexter Interim Chief Executive Officer and Rami Aviram Chief Financial Officer
August 31, 2026
Experienced leadership team to build on established commercial platform and accelerate Lifeward’s next phase of growth with continuity of strategy
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward Reports Strong Second Quarter 2026 Financial Results as Commercial Execution Drives Growth
August 14, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward Ltd (NASDAQ:LFWD) Q1 Revenue Misses Estimates as Strategic Transformation Takes Shape
↗
May 15, 2026
Via
Chartmill
Lifeward to Report Second Quarter 2026 Financial Results on August 14, 2026
August 07, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward Launches Pilot Program with Ottobock Care to Expand National Access to ReWalk® Personal Exoskeleton
August 05, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing
July 07, 2026
Initial $5.6 million provides immediate capital to accelerate commercialization of Lifeward's restorative healthcare platform; additional $5.6 million available upon achievement of defined commercial...
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward (LFWD) Q4 2025 Earnings Transcript
↗
May 21, 2026
Lifeward (LFWD) Q4 2025 Earnings Transcript
Via
The Motley Fool
Topics
World Trade
Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform
May 19, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward (LFWD) Q1 2026 Earnings Transcript
↗
May 15, 2026
Lifeward (LFWD) Q1 2026 Earnings Transcript
Via
The Motley Fool
Topics
Economy
Intellectual Property
World Trade
Lifeward Reports First Quarter 2026 Financial Results
May 15, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward to Report First Quarter 2026 Financial Results on May 15, 2026
May 11, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward Announces New ReWalk® Data Presented at ASIA 2026 Conference Demonstrating a Comprehensive Longitudinal Safety Analysis for a Powered Exoskeleton
May 04, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward Successfully Closes on Strategic Partnership with Oramed
March 25, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results
March 18, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company
March 13, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement
March 11, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
March 10, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward Announces Collaboration With Shirley Ryan AbilityLab to Expand Access for the ReWalk Personal Exoskeleton
March 02, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke Survivors
February 25, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
LFWD Stock Sinks To Record Low On Second Reverse Split In Two Years
↗
February 20, 2026
The company announced it would implement a 1-for-12 reverse stock split effective Feb. 24, 2026.
Via
Stocktwits
Lifeward Announces Reverse Share Split
February 20, 2026
Reverse split initiated as Lifeward enters strategic partnership agreement and repositions as MedTech innovation company
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward’s ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers
February 17, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company
January 13, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward Appoints Bob Marshall as Chairman of the Board
December 19, 2025
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward Expands International Distribution of its ReWalk® Personal Robotic Exoskeleton into Mexico, Thailand, and the United Arab Emirates
December 17, 2025
From
Lifeward Ltd.
Via
GlobeNewswire
Stay updated with the stocks that are on the move in today's after-hours session.
↗
December 03, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via
Chartmill
Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization Approval
December 03, 2025
From
Lifeward Ltd.
Via
GlobeNewswire
UnitedHealthcare Medicare Advantage Plan Issues Prior Authorization Approval for a ReWalk 7 Personal Exoskeleton
November 17, 2025
Approval marks continued progress in expanding reimbursement pathways and accelerating access to advanced personal exoskeleton technology for individuals with spinal cord injury.
From
Lifeward Ltd.
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
